From major journals, first or last author from the Institute for Cancer Research
Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Taskén K, Mahon P(2025) Accelerating precision oncology by converging pragmatic trials and real-world evidence Nat Rev Drug Discov(in press) DOI 10.1038/d41573-025-00047-5, PubMed 40082591
Avershina E, Qureshi AI, Winther-Larsen HC, Rounge TB(2025) Challenges in capturing the mycobiome from shotgun metagenome data: lack of software and databases Microbiome, 13(1), 66 DOI 10.1186/s40168-025-02048-3, PubMed 40055808
Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Taskén K, Mahon P(2025) Accelerating precision oncology by converging pragmatic trials and real-world evidence Nat Rev Drug Discov(in press) DOI 10.1038/d41573-025-00047-5, PubMed 40082591
Lindemann K, Siegenthaler F, Lande KT, Casas-Arozamena C, Nebdal D, Rau TT, Hoivik EA, Mueller MD, Gold RM, Imboden S, Davidson B, Krakstad C, Sørlie T(2025) Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study Gynecol Oncol, 195, 98-105(in press) DOI 10.1016/j.ygyno.2025.03.002, PubMed 40081113